Skip to content

Monday, July 28, 2025

Latest:

Welcome new School of Medicine, Graduate School and School of Health Professions students!
Control-Alt-Delete: Why data integrity matters in medicine
A molecular bridge helps disordered proteins work properly
Patient finds relief after adrenal gland tumor removed by Baylor endocrine surgeon
Can psychedelic mushrooms slow down aging?

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

CALGB 40601 clinical trial

From The Labs

Researchers identified new indicators for HER2+ breast cancer response to therapy

June 17, 2025 Breast Cancer, CALGB 40601 clinical trial, GPRC5A, HER2, proteogenomics, Research, response to treatment, TPBG

Being able to predict the response of cancer to treatment by analyzing a tumor sample before therapy is given would significantly affect clinical outcomes

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma